NO132100B - - Google Patents

Download PDF

Info

Publication number
NO132100B
NO132100B NO205/69A NO20569A NO132100B NO 132100 B NO132100 B NO 132100B NO 205/69 A NO205/69 A NO 205/69A NO 20569 A NO20569 A NO 20569A NO 132100 B NO132100 B NO 132100B
Authority
NO
Norway
Prior art keywords
formula
fluorine
compound
group
hydroxy
Prior art date
Application number
NO205/69A
Other languages
English (en)
Norwegian (no)
Other versions
NO132100C (nl
Inventor
J Elks
G H Phillipps
P J May
Original Assignee
Glaxo Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Lab Ltd filed Critical Glaxo Lab Ltd
Publication of NO132100B publication Critical patent/NO132100B/no
Publication of NO132100C publication Critical patent/NO132100C/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • GPHYSICS
    • G02OPTICS
    • G02BOPTICAL ELEMENTS, SYSTEMS OR APPARATUS
    • G02B7/00Mountings, adjusting means, or light-tight connections, for optical elements
    • G02B7/20Light-tight connections for movable optical elements
    • G02B7/22Extensible connections, e.g. bellows

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Optics & Photonics (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Moulds For Moulding Plastics Or The Like (AREA)
NO205/69A 1968-01-19 1969-01-18 NO132100C (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3100/68A GB1253831A (en) 1968-01-19 1968-01-19 9alpha,21-DIHALOPREGNANE COMPOUNDS

Publications (2)

Publication Number Publication Date
NO132100B true NO132100B (nl) 1975-06-09
NO132100C NO132100C (nl) 1975-09-17

Family

ID=9751941

Family Applications (1)

Application Number Title Priority Date Filing Date
NO205/69A NO132100C (nl) 1968-01-19 1969-01-18

Country Status (14)

Country Link
US (1) US3721687A (nl)
BE (1) BE727109A (nl)
BR (1) BR6905681D0 (nl)
CA (1) CA952900A (nl)
CH (2) CH564563A5 (nl)
DK (1) DK126500B (nl)
ES (1) ES362679A1 (nl)
FR (1) FR2000443A1 (nl)
GB (1) GB1253831A (nl)
IE (1) IE33204B1 (nl)
IL (1) IL31447A (nl)
NL (1) NL6900795A (nl)
NO (1) NO132100C (nl)
SE (1) SE350035B (nl)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1429184A (en) * 1972-04-20 1976-03-24 Allen & Hanburys Ltd Physically anti-inflammatory steroids for use in aerosols
US4044126A (en) * 1972-04-20 1977-08-23 Allen & Hanburys Limited Steroidal aerosol compositions and process for the preparation thereof
US4154748A (en) * 1978-01-20 1979-05-15 The Upjohn Company Phosphate catalyzed acylation of steroidal tertiary alcohols
DE2817988A1 (de) * 1978-04-25 1979-11-08 Hoechst Ag Corticoid 17-alkylcarbonate und verfahren zu deren herstellung
US4336200A (en) * 1980-01-31 1982-06-22 The Upjohn Company 17α-Acyloxy-5β-corticoids
CY1359A (en) * 1981-02-02 1987-08-07 Schering Corp Aromatic heterocyclic esters of steroids, their preparation and pharmaceutical compositions containing them
IT1194178B (it) * 1983-03-29 1988-09-14 Ricerche Steroidi Sirs Spa Soc Processo per la preparazione di 17-esteri di clobetasolo e composti ottenuti
ES2078175B1 (es) * 1993-12-31 1996-10-16 Cusi Lab Formulacion farmaceutica conteniendo clobetasona y tobramicina y sus aplicaciones.
US20090304603A1 (en) * 2001-06-15 2009-12-10 Cuticeuticals, Inc. Topical steroid spray with botanic seed oils
US20040022741A1 (en) * 2001-06-15 2004-02-05 Crutchfield Charles E. Topical steroid spray
AR045536A1 (es) * 2003-08-29 2005-11-02 Ranbaxy Lab Ltd Inhibidores de la fosfodiesterasa tipo -iv
EP1694655A2 (en) * 2003-11-26 2006-08-30 Ranbaxy Laboratories Limited Phosphodiesterase inhibitors
US7915286B2 (en) 2005-09-16 2011-03-29 Ranbaxy Laboratories Limited Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors
US20090221664A1 (en) 2005-10-19 2009-09-03 Abhijit Ray Pharmaceutical compositions of muscarinic receptor antagonists
EP1948167A1 (en) * 2005-10-19 2008-07-30 Ranbaxy Laboratories, Ltd. Compositions of phosphodiesterase type iv inhibitors
WO2008035316A2 (en) * 2006-09-22 2008-03-27 Ranbaxy Laboratories Limited Phosphodiesterase inhibitors
CA2664247A1 (en) * 2006-09-22 2008-03-27 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type-iv
US20080207659A1 (en) * 2007-02-15 2008-08-28 Asit Kumar Chakraborti Inhibitors of phosphodiesterase type 4
US20110130403A1 (en) * 2007-03-14 2011-06-02 Ranbaxy Laboratories Limited Pyrazolo [3, 4-b] pyridine derivatives as phosphodiesterase inhibitors
MX2009009793A (es) * 2007-03-14 2009-10-16 Ranbaxy Lab Ltd Derivados de pirazolo (3,4-b) piridina como inhibidores de fosfodiesterasa.
WO2009045539A2 (en) 2007-10-05 2009-04-09 Nektar Therapeutics Al, Corporation Oligomer-corticosteroid conjugates
EP2111861A1 (en) 2008-04-21 2009-10-28 Ranbaxy Laboratories Limited Compositions of phosphodiesterase type IV inhibitors
CN101812107B (zh) * 2010-04-20 2013-05-01 浙江仙居仙乐药业有限公司 一种合成丙酸氯倍他索的方法
US8900626B2 (en) 2011-06-20 2014-12-02 Senju Usa, Inc. Transdermal drug delivery system and method of using the same

Also Published As

Publication number Publication date
FR2000443A1 (nl) 1969-09-05
DK126500B (da) 1973-07-23
IE33204B1 (en) 1974-04-17
BE727109A (nl) 1969-07-22
SE350035B (nl) 1972-10-16
CH564035A5 (nl) 1975-07-15
DE1902340B2 (de) 1977-06-08
NO132100C (nl) 1975-09-17
US3721687A (en) 1973-03-20
BR6905681D0 (pt) 1973-02-08
DE1902340A1 (de) 1969-09-11
ES362679A1 (es) 1971-02-01
NL6900795A (nl) 1969-07-22
IL31447A0 (en) 1969-03-27
IE33204L (en) 1969-07-19
CH564563A5 (nl) 1975-07-31
GB1253831A (en) 1971-11-17
IL31447A (en) 1973-11-28
CA952900A (en) 1974-08-13

Similar Documents

Publication Publication Date Title
NO132100B (nl)
DE60023531T2 (de) Spezifische acylierte gylcerolverbindungen als weichmacher für polymere
DE69904767T2 (de) Nylon 12, Nylon 12-Zusammensetzungen, Verfahren zur Herstellung von Nylon 12 und röhrenförmiges Formteil aus Nylon 12
EP0315858A1 (de) Lagerstabiler Klebstoff für insbesondere nachchlorierte PVC-Kunststoffe
DE1280838B (de) Verfahren zur Reinigung von Lactiden
DE2605794C3 (de) Polyamidmassen mit verbesserter thermischer Stabilität
EP0000746B1 (de) Neue Organozinnverbindungen, ihre Herstellung und ihre Verwendung
DE69425089T2 (de) Eine Kombination Wärmestabilisator/Gleitmittel für die PVC-Verarbeitung und Methode zur deren Herstellung
DE68914062T2 (de) Synthetische Seifenstücke mit verbesserten Eigenschaften.
DE838213C (de) Verfahren zur Verguetung von Dimethylsilikongummi
SU503519A3 (ru) Способ получени производных 5-нитрохинолина
DE68917110T2 (de) Fluorierte Gelatine und Verfahren zu deren Herstellung.
DE2213927B2 (de) Stabilisierte Polyvinylchloridmassen
DE927269C (de) Verfahren zur Herstellung neuer Derivate des 2-Mercapto-naphthimidazols
DE805565C (de) Plastische Massen
DE2619836A1 (de) Neue schmiermittel fuer thermoplastische materialien und ein verfahren zur herstellung derselben
DE1951034A1 (de) Weisser aktiver Fuellstoff und Verfahren zur Herstellung desselben
JP3535219B2 (ja) 固体のジアシル型有機過酸化物の水性懸濁液
DE965407C (de) Verfahren zur Herstellung monomerer organischer Schwefelverbindungen
DE1745566C3 (de) Verfahren zur Herstellung von Misch polymerisaten aus Vinylchlorid und Fumarsaureestern
DE69613629T2 (de) Thermoplastenmasse zur Bildung einer Dichtung auf einem Verschluss
AT345452B (de) Verfahren zur herstellung von neuen cephalosporinen
DE932675C (de) Verfahren zur Herstellung von Estern des Penicillins mit eine sekundaere Aminogruppe aufweisenden Alkoholen und von Salzen dieser Ester
DE1569201C3 (de) Verwendung von Polyglutamaten zum Herabsetzen der Versprödungstemperatur und zum Erhöhen der Biegsamkeit von Polyvinylchloriden und/oder -acetaten
DE643979C (de) Verfahren zur Darstellung therapeutisch wertvoller Keimdruesenhormonpraeparate